Company news

Share this article:

Amgen said on Monday that 2,200 employees would lose their jobs under a company restructuring that includes about 675 layoffs at its headquarters in Thousand Oaks, CA, The Ventura County Star reported.

The total number of job cuts was close to what the company estimated when it announced in August that 2,200 to 2,600 job cuts were needed as part of a plan to reduce costs.  Amgen has seen decreased revenue during 2007 from its main anemia drug, Aranesp, after studies that raised safety concerns about anemia drugs and changes in how Medicare pays for them.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Panel votes against painkiller

Panel chair Randall Flick said QRxPharma "had not provided sufficient evidence to support a claim that Moxduo is safer than morphine or oxycodone."

Amgen sales rose by 5% in Q1

But demand for Enbrel and Aranesp slipped.

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.